VTE (VENOUS THROMBOEMBOLISM)
Clinical trials for VTE (VENOUS THROMBOEMBOLISM) explained in plain language.
Never miss a new study
Get alerted when new VTE (VENOUS THROMBOEMBOLISM) trials appear
Sign up with your email to follow new studies for VTE (VENOUS THROMBOEMBOLISM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Once-Daily pill cut cancer clot risk? new trial aims to find out
Disease control Recruiting nowThis study tests whether a once-daily dose of the blood thinner apixaban can safely prevent dangerous blood clots in cancer patients at moderate risk. About 996 adults with solid tumors or lymphoma will be randomly assigned to take apixaban twice daily, once daily, or no blood th…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: PHASE3 • Sponsor: University of Vermont • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
Could a simple pill replace daily shots for blood clot prevention in cancer?
Disease control Recruiting nowThis study looks at whether lower doses of two common blood thinner pills (apixaban and rivaroxaban) work as well as standard daily injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will …
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 04, 2026 16:20 UTC